Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Novel Blood Test as a Biomarker in Mental Health
Sponsor: Fraser Health
Summary
This longitudinal, observational study aims to assess whether the characteristics of a novel blood peripheral biomarker can serve as indicators for depression and schizophrenia in patients at the Royal Columbian Hospital Psychiatric Clinics. The study will evaluate whether changes in these biomarker characteristics can help distinguish between depressed patients who do or do not respond to treatment and between individuals experiencing a single psychotic episode and those at risk of progressing to schizophrenia. To achieve this, blood samples and standardized mental health assessments will be collected across three study visits from up to 500 participants, grouped into two study arms based on their diagnosis: Depression (DEP) or Psychosis/Schizophrenia (PSY).
Official title: A Novel Blood Test as a Differential Diagnosis and Drug Efficacy Biomarker in Mental Health
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2025-03-25
Completion Date
2027-08-31
Last Updated
2026-03-05
Healthy Volunteers
No
Conditions
Locations (1)
Royal Columbian Hospital
New Westminster, British Columbia, Canada